The Trump administration's
COVID lab-leak retribution is in full swing: a flu expert was hauled off by the FBI, a coronavirus researcher was indicted in Detroit, two prominent virologists stepped down or were removed from senior roles, and Anthony Fauci, MD, has been subpoenaed to appear before the U.S. Senate. (The Atlantic)
An excerpt:
Even if this thirst for COVID retribution could be satisfied, its supposed higher purpose—to help prevent the next pandemic, by promoting more responsible research—hasn't yet been served. Despite the years of Sturm und Drang about pandemic origins, and the wholesale adoption of the lab-leak theory by the party that controls both Congress and the White House, a shaky status quo still persists in biosafety. The rules for how to work on dangerous pathogens and which sorts of experiments should be allowed aren't clear; oversight is spotty.
A better, more comprehensive system remains a worthy goal. Shortly after President Trump took office, his administration took a few half steps in that direction. Last May, the president issued an executive order meant to limit and track all research that involves the potential enhancement of dangerous pathogens. "This is an historic day—the end of gain-of-function-research funding by the federal government," HHS Secretary Robert F. Kennedy Jr. told reporters at the signing ceremony; NIH director Jay Bhattacharya said gain-of-function work would "go away forever." Yet Ebright and others told me that this project has stalled out. The Office of Science and Technology Policy had been placed in charge of revising the rules on this research by the end of last summer and implementing a national strategy for tracking all gain-of-function research before the end of last year. Those deadlines came and went. No such policies were put in place. (In response to a request for comment on this delay, the White House said that the administration "continues to implement our updated framework to govern, limit, and track dangerous gain-of-function research across the United States.")
In the absence of that administrative work and with little progress being made on the various biosafety laws that have been proposed in Congress, the nation has been left with just the vengeful spectacle of lab-leak prosecutions. In effect, research policy is being handled by the Department of Justice. America's doctor may soon be dragged out to testify once more: The science that he championed appears to be unfettered; the scientists he funded are at risk of ending up in chains.
***
The Atlantic link is a gift article via via
MedPage Today, which linked to this stories in the same issue:
Are MAGA and MAHA Heading for Divorce? (Rolling Stone)
Firing Cancer Screening Experts Will Not Make Us Healthy Again (NYT Opinion)
NIH likely to award fewer grants as it races to spend 2026 budget (Science.org)
Palantir Has a Hand in NIH's Most Ambitious Health Initiative (Mother Jones)
Provision buried in controversial U.S. rule change would help people legally challenge 'woke' federal research (Science.org)
A congressional committee has opened an inquiry into Bristol Myers Squibb and Pfizer's use of clinical trial sites in China (Endpoints News).
If you were a conspiracy theorist, you might see the pattern emerging from these headlines, too; but maybe this is too obvious, too mainstream, not sexy or exciting enough.